Cava Group, Inc. <CAVA.N>: D.A. Davidson Cuts Target Price to $75 From $84
CAVA•Related News
AMN Healthcare white paper sees persistent US staffing strain across clinicians through 2030
AMN•
WeRide 2Q Revenue RMB231.7 Million (Us$34.2 Million)
WRD•
Israel's IceCure Medical H1 revenue rises on higher system, probe sales
ICCM•
Dyadic net loss widens 18.8% to USD 2.12 million in Q2 FY26; revenue slips 0.6% to USD 961,138
DYAI•
Alico CEO Kiernan to present at Midwest IDEAS investor conference
ALCO•